Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK

PURPOSE: Patients with severe COPD are at high risk of experiencing disease exacerbations, which require additional treatment and are associated with elevated mortality and increased risk of future exacerbations. Some patients continue to experience exacerbations despite receiving triple inhaled the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiff, Chris, Ruiz, Sandrine, Varol, Nebibe, Gibson, Danny, Davies, Andrew, Purkayastha, Debasree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128277/
https://www.ncbi.nlm.nih.gov/pubmed/30214188
http://dx.doi.org/10.2147/COPD.S167730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128277/
https://www.ncbi.nlm.nih.gov/pubmed/30214188
http://dx.doi.org/10.2147/COPD.S167730

Ejemplares similares